2-bromo-N-(2,5-dichlorothiophen-3-ylsulfonyl)-N-phenylacetamide

ID: ALA1171238

PubChem CID: 49798556

Max Phase: Preclinical

Molecular Formula: C12H8BrCl2NO3S2

Molecular Weight: 429.14

Molecule Type: Small molecule

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  O=C(CBr)N(c1ccccc1)S(=O)(=O)c1cc(Cl)sc1Cl

Standard InChI:  InChI=1S/C12H8BrCl2NO3S2/c13-7-11(17)16(8-4-2-1-3-5-8)21(18,19)9-6-10(14)20-12(9)15/h1-6H,7H2

Standard InChI Key:  XOLGJVQMYMQCNT-UHFFFAOYSA-N

Molfile:  

     RDKit          2D

 21 22  0  0  0  0  0  0  0  0999 V2000
   -2.6931  -22.9083    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.6943  -23.7357    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.9794  -24.1485    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2630  -23.7352    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2659  -22.9047    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.9812  -22.4955    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.5529  -22.4895    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.1631  -22.8993    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
    0.8760  -22.4841    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.1662  -23.7243    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.8750  -23.3083    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.8722  -24.1294    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.6523  -24.3857    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
    2.1371  -23.7230    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.6567  -23.0573    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.9621  -23.7258    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
    0.2031  -24.6120    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
   -0.5561  -21.6645    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.1569  -21.2493    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2721  -21.2547    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2752  -20.4297    0.0000 Br  0  0  0  0  0  0  0  0  0  0  0  0
  2  3  1  0
  8 11  1  0
 11 12  2  0
  5  6  2  0
  6  1  1  0
  1  2  2  0
  5  7  1  0
 12 13  1  0
 13 14  1  0
 14 15  2  0
 15 11  1  0
  3  4  2  0
 14 16  1  0
  7  8  1  0
 12 17  1  0
  7 18  1  0
  8  9  2  0
 18 19  2  0
  4  5  1  0
 18 20  1  0
  8 10  2  0
 20 21  1  0
M  END

Associated Targets(Human)

CCNH Tbio Cyclin-dependent kinase 7/ cyclin H (714 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CCND1 Tchem CDK6/cyclin D1 (322 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CDK1 Tchem Cyclin-dependent kinase 1/cyclin B1 (1887 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CDK2 Tchem Cyclin-dependent kinase 2/cyclin A (2220 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
DU-145 (51482 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
LoVo (4724 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
MCF7 (126967 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CDK7 Tchem Cyclin-dependent kinase 7 (1512 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CDK6 Tclin Cyclin-dependent kinase 6 (1724 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CDK2 Tchem Cyclin-dependent kinase 2 (9050 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CDK1 Tchem Cyclin-dependent kinase 1 (3927 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Pfmrk Protein kinase Pfmrk (149 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Plasmodium falciparum (966862 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
RAW264.7 (28094 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Biocomponents

Calculated Properties

Molecular Weight: 429.14Molecular Weight (Monoisotopic): 426.8506AlogP: 4.17#Rotatable Bonds: 4
Polar Surface Area: 54.45Molecular Species: NEUTRALHBA: 4HBD:
#RO5 Violations: HBA (Lipinski): 4HBD (Lipinski): #RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: CX LogP: 4.49CX LogD: 4.49
Aromatic Rings: 2Heavy Atoms: 21QED Weighted: 0.69Np Likeness Score: -1.65

References

1. Caridha D, Kathcart AK, Jirage D, Waters NC..  (2010)  Activity of substituted thiophene sulfonamides against malarial and mammalian cyclin dependent protein kinases.,  20  (13): [PMID:20627564] [10.1016/j.bmcl.2010.05.039]
2. Rotella DP..  (2012)  Recent results in protein kinase inhibition for tropical diseases.,  22  (22): [PMID:23063403] [10.1016/j.bmcl.2012.09.044]

Source